Back
to sessions
Sep 28
Science Highlights
SH 07 - Head and Neck Cancer - Science Highlights
session DESCRIPTION
The following abstracts will be highlighted in this session:
- LBA 02 — Primary Results for the Phase III Trial of Toxicity Reduction using Proton Beam Therapy for Oropharyngeal Cancer (TORPEdO; CRUK/18/010) — David Thomson
- 312 — A Phase II Trial of Hypofractionated Radiotherapy for Older Adults with Head and Neck Squamous Cell Carcinoma — Daniel Dickstein
- 241 — A Phase II Randomized Study of Proton vs. Intensity-Modulated Radiation Therapy in the Treatment of Unilateral Head and Neck Cancer — Edward Dee
- 157 — A Multi-Site Single-Arm Phase I/II Trial of Selective Avoidance of Nodal VolumEs at Minimal Risk (SAVER) in the Contralateral N0 Neck of Patients with p16-Positive Oropharynx Cancer — Jason Molitoris
- 154 — The Influence of Chemo-Radiotherapy Dose and Radiotherapy Volumes on Peripheral Immunity in HPV+ Oropharyngeal Cancer — Nadeem Riaz
- 1090 — Variance in Practice Patterns among Radiation Oncologists Treating Oropharyngeal Cancers — Morgan Bailey
- 244 — Proton vs. Photon for Nasopharyngeal Carcinoma: Toxicity and Survival in a Phase 2 Randomized Study — Lin Kong
Credits
| AMA PRA Category 1 Credits: | 0.50 |
| CAMPEP Credits: | 0.50 |
Presentations
-
08:00am - 08:30am PT
Discussant
Speaker: Danielle Margalit, MD, MPH - Harvard Medical School, Boston